Literature DB >> 23391779

Two cases of malignant struma ovarii with metastasis to pelvic bone.

Rachel A Steinman1, Ismary O De Castro, Muhammad Shrayyef, Vaseem Chengazi, Ellen Giampoli, Paul Van Der Sloot, Laura M Calvi, Steven D Wittlin, Stephen R Hammes, Runhua Hou.   

Abstract

Histologically, malignant struma ovarii metastasizes rarely, and only a few cases reported bone metastasis. Here, we describe 2 cases of biologically malignant struma ovarii with pelvic bone metastasis. Case 1 is a 22-year-old female who was found to have a large left ovarian mass during routine prenatal ultrasound. Papillary thyroid cancer arising in struma ovarii was identified after laparoscopic salpingo-oophorectomy. After total thyroidectomy, radioactive iodine whole-body scan revealed extrathyroidal iodine uptake in left anterior pelvis. Subsequent I-131 treatment resolved the pelvic metastasis. Case 2 is a 49-year-old female who was diagnosed with malignant struma ovarii in 1996 and presented in 2007 with pelvic recurrence and extensive left hip metastasis. Treatment with resection of the pelvic tumor, total thyroidectomy, and multiple I-131 ablation led to eventual resolution of the abdominal and left hip foci. In conclusion, we present 2 rare cases of malignant struma ovarii, both with metastasis to the pelvic bone. This report makes pelvic bone the most frequent site for bone metastasis in malignant struma ovarii. It also emphasizes the importance of total thyroidectomy in allowing identification and treatment of bony metastasis with radioactive iodine.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23391779     DOI: 10.1159/000345863

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  4 in total

1.  Spinal metastasis from struma ovarii: case report and review of the literature.

Authors:  Kazuyoshi Kobayashi; Shiro Imagama; Shin Tsunekawa; Kaori Hosokawa; Minemori Watanabe; Zenya Ito; Kei Ando; Naoki Ishiguro
Journal:  Asian Spine J       Date:  2015-04-15

2.  Usefulness of (131)I-SPECT/CT and (18)F-FDG PET/CT in Evaluating Successful (131)I and Retinoic Acid Combined Therapy in a Patient with Metastatic Struma Ovarii.

Authors:  Hyo Jung Seo; Young Hoon Ryu; Inki Lee; Hye Sook Min; Keon Wook Kang; Dong Soo Lee; Dae-Hee Lee; June-Key Chung
Journal:  Nucl Med Mol Imaging       Date:  2014-09-25

3.  Long-term survival in metastatic malignant struma ovarii treated with oral chemotherapy: A case report.

Authors:  Masayo Ukita; Hidekatsu Nakai; Yasushi Kotani; Takako Tobiume; Eiji Koike; Isao Tsuji; Ayako Suzuki; Masaki Mandai
Journal:  Oncol Lett       Date:  2014-10-03       Impact factor: 2.967

4.  Synchronous papillary carcinoma thyroid with malignant struma ovarii: A management dilemma.

Authors:  Arvind Krishnamurthy; Vijayalakshmi Ramshankar; Venkatesh Vaidyalingam; Urmila Majhi
Journal:  Indian J Nucl Med       Date:  2013-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.